A Comparison of Protein Stability in Prefillable Syringes Made of Glass and Plastic

The development of protein therapeutics requires stabilization of these labile molecules during shipment and storage. Biologics, particularly monoclonal antibodies, are frequently packaged at high concentration in prefillable syringes traditionally made of glass. However, some biologics are unstable in glass due to sensitivity to silicone oil, tungsten, glue, or metal ions. Syringes made from the plastic cyclic olefin polymer, Daikyo Crystal Zenith® (CZ), with a Flurotec-laminated piston, have none of these issues. This study compared the stability of several proteins including biotherapeutics when stored up to 14 months at 5 °C and 25 °C in prefillable siliconized syringes made of glass or silicone oil-free CZ syringes, and when subjected to mild agitation by end-over-end rotation at room temperature. At each time point, proteins were analyzed by several techniques including turbidity, size exclusion high-performance liquid chromatography, reversed phase high-performance liquid chromatography, ion-exchange chromatography, electrophoresis, and light scattering to monitor changes in aggregation and degradation. The results show that proteins have comparable stability when stored in glass syringes or in syringes made of CZ sterilized by E-beam or autoclave. In addition, proteins stressed by agitation were generally more stable and aggregated less in syringes made of CZ than in ones made of glass. LAY ABSTRACT: Biotherapeutic protein drugs such as monoclonal antibodies are frequently packaged at high concentration in prefillable syringes, which allows the drug to be directly administered by the patient or caregiver. Protein drugs, or biologics, can be unstable, and may aggregate, particularly when shaken. These aggregates can be immunogenic, stimulating the body's immune system to produce antibodies that can reduce the drug's efficacy. Although prefillable syringes are traditionally made of glass, some biologics are unstable in glass syringes due to the presence of substances used in their manufacture, including silicone oil, which is necessary for lubricity. Syringes made from the plastic cyclic olefin polymer, Daikyo Crystal Zenith® (CZ), have none of these issues. This study compared the stability of several biotherapeutic proteins when stored up to 14 months at 5 °C and 25 °C in prefillable siliconized syringes made of glass or silicone oil-free CZ syringes, and when mildly agitated at room temperature. Proteins were analyzed by several techniques to detect changes in aggregation and degradation. The results show that biotherapeutic proteins have similar stability whether stored in syringes made of glass or CZ. In addition, proteins subjected to agitation were generally more stable and aggregated less in CZ syringes than in glass syringes.

[1]  Sung Chul Kim,et al.  Chemical structure and physical properties of cyclic olefin copolymers (IUPAC Technical Report) , 2005 .

[2]  Theodore W Randolph,et al.  IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: a model for siliconized primary containers. , 2013, Journal of pharmaceutical sciences.

[3]  Theodore W Randolph,et al.  Precipitation of a monoclonal antibody by soluble tungsten. , 2009, Journal of pharmaceutical sciences.

[4]  Franco Lombardo,et al.  Stabilization of Pharmaceuticals to Oxidative Degradation , 2002, Pharmaceutical development and technology.

[5]  R T Borchardt,et al.  Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization. , 1995, Biotechnology and bioengineering.

[6]  Linda O. Narhi,et al.  Chemical Modifications in Therapeutic Protein Aggregates Generated under Different Stress Conditions , 2011, The Journal of Biological Chemistry.

[7]  Yoshihiko Abe,et al.  Assessment of the effects of sterilization methods on protein drug stability by elucidating decomposition mechanism and material analysis. , 2015, International journal of pharmaceutics.

[8]  Yoshihiko Abe,et al.  Functional Evaluation and Characterization of a Newly Developed Silicone Oil-Free Prefillable Syringe System , 2014, Journal of pharmaceutical sciences.

[9]  D. Nesta,et al.  Evaluating Freeze–Thaw Processes in Biopharmaceutical Development , 2015 .

[10]  S. Singh,et al.  An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics. , 2010, Journal of pharmaceutical sciences.

[11]  William F. Weiss,et al.  Nonnative protein polymers: structure, morphology, and relation to nucleation and growth. , 2007, Biophysical journal.

[12]  Vincent J. Sullivan,et al.  Evaluation of the effect of syringe surfaces on protein formulations. , 2011, Journal of pharmaceutical sciences.

[13]  R. Ionescu,et al.  Fragmentation of monoclonal antibodies , 2011, mAbs.

[14]  Bruce A Kerwin,et al.  Protect from light: photodegradation and protein biologics. , 2007, Journal of pharmaceutical sciences.

[15]  Steven Kozlowski,et al.  Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. , 2009, Journal of pharmaceutical sciences.

[16]  J. Tamada,et al.  Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. R. Middaugh,et al.  Silicone oil induced aggregation of proteins. , 2005, Journal of pharmaceutical sciences.

[18]  Yasser Nashed-Samuel,et al.  Interactions between Therapeutic Proteins and Acrylic Acid Leachable , 2012, PDA Journal of Pharmaceutical Science and Technology.

[19]  Yoshihiko Abe,et al.  A Strategy for the Prevention of Protein Oxidation by Drug Product in Polymer-Based Syringes , 2015, PDA Journal of Pharmaceutical Science and Technology.

[20]  R. Lockey,et al.  Immunologic responses to therapeutic biologic agents. , 2008, Journal of investigational allergology & clinical immunology.

[21]  Theodore W Randolph,et al.  Protein aggregation and particle formation in prefilled glass syringes. , 2014, Journal of pharmaceutical sciences.

[22]  Y. J. Wang,et al.  The relative rate of immunoglobulin gamma 1 fragmentation. , 2011, Journal of pharmaceutical sciences.

[23]  A. Rosenberg,et al.  Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.

[24]  P. Mangiagalli,et al.  Silicone-oil-based subvisible particles: their detection, interactions, and regulation in prefilled container closure systems for biopharmaceuticals. , 2012, Journal of pharmaceutical sciences.

[25]  Yijia Jiang,et al.  Root Cause Analysis of Tungsten-Induced Protein Aggregation in Pre-filled Syringes. , 2010, PDA journal of pharmaceutical science and technology.

[26]  Theodore W Randolph,et al.  Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution. , 2009, Journal of pharmaceutical sciences.

[27]  Joey Pollastrini,et al.  Tungsten-induced protein aggregation: solution behavior. , 2009, Journal of pharmaceutical sciences.

[28]  Kiichi Fukui,et al.  Effects of Syringe Material and Silicone Oil Lubrication on the Stability of Pharmaceutical Proteins , 2014, Journal of pharmaceutical sciences.